Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors

A compound of Formula I:

• any of its isomers or any mixture of its isomers,
• or a pharmaceutically acceptable salt thereof,
• wherein
• R1 represents a quinolyl, isoquinolyl or pyridyl group;
• which group is optionally substituted with one or more substituents independently selected from the group consisting of:
• halo, trifluoromethyl, trifluoromethoxy, cyano, hydroxy, amino, nitro, alkoxy, cycloalkoxy, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl and alkynyl;
• n is 1 or 2;
• R2 and R3 independent of each other represent hydrogen or alkyl;
• the bond . . . represents a single or a double bond;
• R4 and R5 independent of each other represent hydrogen or alkyl;
• or R4 and R5 together with the carbon atoms to which they are attached form a three-membered carbocyclic ring;
• and
• R6 represents hydrogen or alkyl.